AtriCure Operating Expenses 2010-2025 | ATRC
AtriCure operating expenses from 2010 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.
| AtriCure Annual Operating Expenses (Millions of US $) |
|
|---|---|
| 2024 | $505 |
| 2023 | $426 |
| 2022 | $373 |
| 2021 | $219 |
| 2020 | $251 |
| 2019 | $264 |
| 2018 | $219 |
| 2017 | $200 |
| 2016 | $186 |
| 2015 | $156 |
| 2014 | $124 |
| 2013 | $93 |
| 2012 | $77 |
| 2011 | $69 |
| 2010 | $62 |
| 2009 | $70 |
| AtriCure Quarterly Operating Expenses (Millions of US $) |
|
|---|---|
| 2025-06-30 | $142 |
| 2025-03-31 | $130 |
| 2024-12-31 | $139 |
| 2024-09-30 | $123 |
| 2024-06-30 | $123 |
| 2024-03-31 | $120 |
| 2023-12-31 | $115 |
| 2023-09-30 | $106 |
| 2023-06-30 | $105 |
| 2023-03-31 | $99 |
| 2022-12-31 | $92 |
| 2022-09-30 | $94 |
| 2022-06-30 | $98 |
| 2022-03-31 | $89 |
| 2021-12-31 | $86 |
| 2021-09-30 | $-28 |
| 2021-06-30 | $86 |
| 2021-03-31 | $75 |
| 2020-12-31 | $75 |
| 2020-09-30 | $59 |
| 2020-06-30 | $48 |
| 2020-03-31 | $69 |
| 2019-12-31 | $77 |
| 2019-09-30 | $65 |
| 2019-06-30 | $63 |
| 2019-03-31 | $59 |
| 2018-12-31 | $56 |
| 2018-09-30 | $56 |
| 2018-06-30 | $51 |
| 2018-03-31 | $56 |
| 2017-12-31 | $48 |
| 2017-09-30 | $49 |
| 2017-06-30 | $52 |
| 2017-03-31 | $51 |
| 2016-12-31 | $49 |
| 2016-09-30 | $45 |
| 2016-06-30 | $47 |
| 2016-03-31 | $45 |
| 2015-12-31 | $46 |
| 2015-09-30 | $38 |
| 2015-06-30 | $37 |
| 2015-03-31 | $35 |
| 2014-12-31 | $34 |
| 2014-09-30 | $27 |
| 2014-06-30 | $29 |
| 2014-03-31 | $33 |
| 2013-12-31 | $27 |
| 2013-09-30 | $23 |
| 2013-06-30 | $22 |
| 2013-03-31 | $21 |
| 2012-12-31 | $20 |
| 2012-09-30 | $19 |
| 2012-06-30 | $20 |
| 2012-03-31 | $19 |
| 2011-12-31 | $18 |
| 2011-09-30 | $16 |
| 2011-06-30 | $18 |
| 2011-03-31 | $17 |
| 2010-12-31 | $17 |
| 2010-09-30 | $15 |
| 2010-06-30 | $15 |
| 2010-03-31 | $16 |
| 2009-12-31 | $16 |
| 2009-09-30 | $18 |
| 2009-06-30 | $15 |
| 2009-03-31 | $22 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.770B | $0.465B |
| AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $226.730B | 26.59 |
| Boston Scientific (BSX) | United States | $152.695B | 36.41 |
| Stryker (SYK) | United States | $145.892B | 29.70 |
| EssilorLuxottica (ESLOY) | France | $145.168B | 0.00 |
| Medtronic (MDT) | Ireland | $118.964B | 16.88 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.349B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.447B | 24.82 |
| ResMed (RMD) | United States | $41.892B | 29.96 |
| Agilent Technologies (A) | United States | $33.562B | 21.88 |
| GE HealthCare Technologies (GEHC) | United States | $33.407B | 15.70 |
| Terumo (TRUMY) | Japan | $27.938B | 33.10 |
| Koninklijke Philips (PHG) | Netherlands | $26.432B | 17.48 |
| Insulet (PODD) | United States | $22.742B | 76.20 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.317B | 12.93 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.894B | 0.00 |
| Baxter (BAX) | United States | $12.127B | 9.37 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.703B | 28.30 |
| Lantheus Holdings (LNTH) | United States | $3.806B | 10.29 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.452B | 24.15 |
| Prestige Consumer Healthcare (PBH) | United States | $3.193B | 14.16 |
| Perrigo (PRGO) | Ireland | $3.169B | 7.91 |
| ICU Medical (ICUI) | United States | $3.035B | 20.67 |
| Haemonetics (HAE) | United States | $2.559B | 11.42 |
| LeMaitre Vascular (LMAT) | United States | $2.151B | 46.14 |
| Curaleaf Holdings (CURLF) | Canada | $1.944B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.753B | 11.03 |
| Green Thumb Industries (GTBIF) | United States | $1.751B | 75.18 |
| AdaptHealth (AHCO) | United States | $1.269B | 18.04 |
| Phibro Animal Health (PAHC) | United States | $1.267B | 16.19 |
| Tilray Brands (TLRY) | Canada | $1.255B | 0.00 |
| Neogen (NEOG) | United States | $1.203B | 19.10 |
| Acuren (TIC) | United States | $1.182B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.174B | 2450.00 |
| Valneva SE (VALN) | France | $1.033B | 0.00 |
| InMode (INMD) | Israel | $0.904B | 8.37 |
| Kestra Medical Technologies (KMTS) | United States | $0.826B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.654B | 0.00 |
| SNDL (SNDL) | Canada | $0.568B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.557B | 0.00 |
| ZimVie (ZIMV) | United States | $0.534B | 20.60 |
| Surmodics (SRDX) | United States | $0.527B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.506B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.458B | 15.76 |
| CeriBell (CBLL) | United States | $0.447B | 0.00 |
| Evolus (EOLS) | United States | $0.433B | 0.00 |
| Owens & Minor (OMI) | United States | $0.421B | 3.73 |
| Capricor Therapeutics (CAPR) | United States | $0.352B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.329B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.329B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.298B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.289B | 0.00 |
| Omeros (OMER) | United States | $0.288B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.281B | 0.00 |
| Brainsway (BWAY) | Israel | $0.281B | 57.12 |
| Viemed Healthcare (VMD) | United States | $0.268B | 20.35 |
| Vireo Growth (VREOF) | United States | $0.244B | 0.00 |
| High Tide (HITI) | Canada | $0.242B | 0.00 |
| Cerus (CERS) | United States | $0.240B | 0.00 |
| Quanterix (QTRX) | United States | $0.230B | 0.00 |
| Exagen (XGN) | United States | $0.215B | 0.00 |
| Organigram Global (OGI) | Canada | $0.205B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.205B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.184B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 15.28 |
| FitLife Brands (FTLF) | United States | $0.157B | 19.36 |
| Biote (BTMD) | United States | $0.149B | 4.95 |
| Jushi Holdings (JUSHF) | United States | $0.121B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.098B | 0.00 |
| MacroGenics (MGNX) | United States | $0.096B | 0.00 |
| Jin Medical (ZJYL) | China | $0.095B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.07 |
| Safety Shot (SHOT) | United States | $0.088B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.081B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.069B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.055B | 32.16 |
| Veru (VERU) | United States | $0.051B | 0.00 |
| Zynex (ZYXI) | United States | $0.046B | 0.00 |
| Nephros (NEPH) | United States | $0.046B | 35.83 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 13.95 |
| Trinity Biotech (TRIB) | Ireland | $0.028B | 0.00 |
| Senestech (SNES) | United States | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |